NASDAQ: ALMSAlumis Inc Stock Ownership - Who owns Alumis?
Insider buying vs selling
Have Alumis Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Foresite Capital Management VI LLC | 10% Owner | 2025-05-06 | 20,000 | $4.34 | $86.80kBuy |
| James B. Tananbaum | Director | 2025-05-06 | 20,000 | $4.34 | $86.80kBuy |
| Foresite Labs LLC | 10% Owner | 2025-05-06 | 20,000 | $4.34 | $86.80kBuy |
| Srinivas Akkaraju | Director | 2025-05-05 | 138,368 | $4.58 | $633.73kBuy |
| Srinivas Akkaraju | Director | 2025-05-05 | 22,002 | $5.27 | $115.95kBuy |
| Foresite Capital Management VI LLC | 10% Owner | 2025-05-02 | 25,000 | $4.62 | $115.50kBuy |
| Srinivas Akkaraju | Director | 2025-05-02 | 159,920 | $4.55 | $727.64kBuy |
| Foresite Labs LLC | 10% Owner | 2025-05-02 | 25,000 | $4.62 | $115.50kBuy |
| James B. Tananbaum | Director | 2025-05-02 | 25,000 | $4.62 | $115.50kBuy |
| Alan Colowick | Director | 2025-04-02 | 2,300 | $7.49 | $17.24kBuy |
ALMS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ALMS insiders and whales buy or sell their stock.
ALMS Shareholders
What type of owners hold Alumis Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ayurmaya Capital Management Company LP | 14.55% | 15,139,707 | $70.55M | Insider |
| Ayurmaya Capital Management Company LP | 14.55% | 15,139,707 | $70.55M | Institution |
| Foresite Capital Management V LLC | 5.55% | 5,779,348 | $26.93M | Institution |
| Srinivas Akkaraju | 4.61% | 4,801,370 | $22.37M | Insider |
| Samsara Biocapital LLC | 4.61% | 4,801,370 | $22.37M | Institution |
| Venbio Partners LLC | 4.44% | 4,619,803 | $21.53M | Institution |
| Foresite Capital Management VI LLC | 4.08% | 4,247,670 | $19.79M | Institution |
| Blackrock Inc | 4.01% | 4,175,713 | $19.46M | Institution |
| Vanguard Group Inc | 3.27% | 3,404,211 | $15.86M | Institution |
| Nextech Invest Ltd | 2.80% | 2,915,998 | $13.59M | Institution |
ALMS vs Biotech Stocks
Alumis Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.